Redeye: Bioservo - High activity level
Redeye saw sales that were in line with our expectations. The positive Carbonhand development helped sales to recover from the weak previous quarter. The cost-cutting is having an effect, and even slightly faster than expected. Carbonhand in Europe has a positive momentum, and we expect that there will be orders from the US soon. The report, in line with our lowered expectations, makes us make some small changes.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/